An observational study in Cerebral Palsy, Sleep Disorders in Children and Caregiver Burden, sponsored by Selim Sezikli. Completed at 1 site in Turkey (Türkiye). Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by Selim Sezikli · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 328 studies in Cerebral Palsy with a site in Turkey — 43 open to participants now, 50 under way, none of them phase 3. Cerebral Palsy · Turkey.
Among the 328 studies in Cerebral Palsy with a site in Turkey, this one is the 71st largest by enrollment of the 138 observational ones that give a count, is one of 31 that started in 2025, is one of 138 observational ones, and was the 284th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →43 of the 328 studies in Cerebral Palsy with a site in Turkey are open now. Recruiting first, the newest first:
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 2–7
Diskapi Yildirim Beyazit Education and Research Hospital · Sites in Turkey
Ages 3–18
Bahçeşehir University · Sites in Turkey
Ages 7–16
Yeditepe University · Sites in Turkey
Ages 18–30
Medipol University · Sites in Turkey
Ages 6–15
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 2 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
328 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 31 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 61 is close to the median of 63 across 474 observational studies indexed under Cerebral Palsy.
Median enrollment 32 across the 190 interventional studies, 63 across the 138 observational. Of the 244 that completed or were terminated, 12 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 328 have an industry lead sponsor. The 10 most frequent:
Selim Sezikli is the lead sponsor of 3 studies on the registry; none are open to participants now.
Selim Sezikli has 1 study filed under Cerebral Palsy — fewer than ten, so there is no comparison to draw.
10 of the studies in Cerebral Palsy with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07836517Yeditepe UniversitySensory-Motor Integration Versus Virtual Reality-Based Exercise in Children With Cerebral Palsy | 2026-11 |
| NCT07681947Yeditepe UniversityA Gamified Breathing and Postural Awareness Education Model for Children With Cerebral Palsy | 2026-11-27 |
| NCT06769178Yeditepe UniversityHow Much Virtual Reality Intervention Improve the Balance of Patients With Cerebral Palsy | 2026-12 |
| NCT07622875Ankara Etlik City HospitalTranscutaneous Diaphragmatic Electrical Stimulation and Pulmonary Function in Non-Ambulatory Cerebral Palsy | 2026-12-01 |
| NCT07846917Atılım UniversitySleep Quality, Caregiver Burden, Stress, and Self-Efficacy in Parents of Children With Spastic Diplegic Cerebral Palsy: A Comparison by Night Orthosis Use | 2026-12-20 |
Add all 10 to your calendar (.ics) → With an account.
Among the 328 studies in Cerebral Palsy with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Cerebral palsy (CP) is a lifelong condition affecting movement and posture, often requiring substantial care from family members. Children with CP frequently experience sleep disturbances associated with motor impairment, pain, seizures, and other clinical factors. Sleep difficulties may also be associated with poor sleep quality, psychological symptoms, and increased burden among caregivers.
This single-center, observational, cross-sectional study evaluated sleep characteristics in children with CP, caregiver sleep quality, and caregiver burden, as well as their associations with functional status and caregiver psychological symptoms.
The study included 61 children with CP and their primary caregivers. Eligible children were aged 2-18 years. Children's sleep characteristics were assessed using a 33-item parent-reported questionnaire adapted from the Children's Sleep Habits Questionnaire (CSHQ), which was not identical to the validated Turkish CSHQ. Children's functional characteristics were evaluated using GMFCS, MACS, and CFCS. Caregiver sleep quality, caregiver burden, and psychological symptoms were assessed using the Pittsburgh Sleep Quality Index (PSQI), Zarit Burden Interview (ZBI), and Hospital Anxiety and Depression Scale (HADS), respectively.
The study was designed to examine associations among child sleep characteristics, caregiver sleep quality, caregiver burden, and psychological well-being.
Cerebral palsy (CP) is a common cause of motor disability in childhood and is frequently associated with long-term care needs. Sleep disturbances are common among children with CP and may coexist with motor impairment, epilepsy, pain, and behavioral difficulties. Caregivers may experience substantial physical and psychological demands, including sleep problems, anxiety, depressive symptoms, and caregiver burden.
This single-center, observational, cross-sectional study was conducted in the outpatient Physical Medicine and Rehabilitation clinics of Istanbul Physical Medicine and Rehabilitation Training and Research Hospital, Türkiye. The study initially planned to recruit at least 40 child-caregiver pairs. Data collection was completed with 61 children diagnosed with CP and their primary caregivers. Participants were recruited through convenience sampling and voluntary participation.
Children were eligible if they were aged 2-18 years with a diagnosis of CP and their adult primary caregivers were evaluated. Children's functional characteristics were classified using the Gross Motor Function Classification System (GMFCS), Manual Ability Classification System (MACS), and Communication Function Classification System (CFCS). Spasticity was evaluated using the Modified Ashworth Scale.
Children's sleep characteristics were assessed using a 33-item parent-reported questionnaire adapted from the Children's Sleep Habits Questionnaire (CSHQ). The questionnaire administered in this study differed in item wording and scoring structure from the validated Turkish CSHQ; therefore, the resulting scores should not be considered directly equivalent to those obtained from the validated instrument.
Caregiver sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), caregiver burden using the Zarit Burden Interview (ZBI), and anxiety and depressive symptoms using the Hospital Anxiety and Depression Scale (HADS).
The study examined associations among children's sleep characteristics, functional status, caregiver sleep quality, caregiver burden, and psychological symptoms using descriptive and inferential statistical methods. Analyses involving the adapted child sleep questionnaire were interpreted as exploratory because of differences from the validated CSHQ instrument.
The study population consisted of children aged 2-18 years diagnosed with cerebral palsy and their primary caregivers (parents or legal guardians aged 18 years or older). Participants were recruited from the outpatient clinics of Istanbul Physical Medicine and Rehabilitation Training and Research Hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This group comprised 61 children aged 2-18 years with cerebral palsy and their primary caregivers. Children underwent functional assessments using GMFCS, MACS, and CFCS, and spasticity assessment using the Modified Ashworth Scale. Children's sleep characteristics were evaluated using a 33-item questionnaire adapted from the CSHQ. Caregiver sleep quality, caregiver burden, and psychological symptoms were assessed using the PSQI, ZBI, and HADS, respectively. No experimental intervention was administered.
Child Sleep Quality Assessed by a 33-Item Parent-Reported Questionnaire Adapted From the Children's Sleep Habits Questionnaire (CSHQ)
Sleep characteristics of children with cerebral palsy were assessed using a 33-item parent-reported questionnaire adapted from the CSHQ. The questionnaire administered differed from the validated Turkish CSHQ in item wording, ordering and scoring, so the scores are not equivalent to those of the validated instrument and analyses involving this measure were exploratory.
Time frame: Day 1 (single assessment at baseline)
Caregiver Sleep Quality Assessed by Pittsburgh Sleep Quality Index (PSQI)
Caregiver sleep quality was measured using the Pittsburgh Sleep Quality Index (PSQI), which evaluates sleep patterns and disturbances over the previous month.
Time frame: Day 1 (single assessment at baseline)
Caregiver Burden Assessed by Zarit Burden Interview (ZBI)
Caregiver burden was assessed using the Zarit Burden Interview (ZBI), a validated questionnaire evaluating the impact of caregiving on emotional, physical, and social well-being.
Time frame: Day 1 (single assessment at baseline)
Child Functional Level Assessed by Gross Motor Function Classification System (GMFCS)
Functional motor levels of the children were classified according to the GMFCS, a standardized 5-level system describing gross motor function.
Time frame: Day 1 (single assessment at baseline)
Manual Ability Assessed by Manual Ability Classification System (MACS)
Hand function and manual ability of the children were evaluated using the MACS, a validated classification system for children with cerebral palsy.
Time frame: Day 1 (single assessment at baseline)
Communication Function Assessed by Communication Function Classification System (CFCS)
Communication ability of the children was assessed using the CFCS, which categorizes functional communication performance in daily life.
Time frame: Day 1 (single assessment at baseline)
Spasticity Assessed by Modified Ashworth Scale (MAS)
Muscle spasticity was measured using the Modified Ashworth Scale (MAS), a widely used clinical tool for grading resistance to passive movement.
Time frame: Day 1 (single assessment at baseline)
Caregiver Psychological Status Assessed by Hospital Anxiety and Depression Scale (HADS)
Caregivers' psychological health was evaluated using the HADS, a self-reported screening tool for symptoms of anxiety and depression.
Time frame: Day 1 (single assessment at baseline)
Plan to share: Yes — De-identified individual participant data underlying the published results will be shared, comprising the children's clinical and functional characteristics and the caregiver-reported questionnaire scores. Direct identifiers have been removed; the dataset is pseudonymised rather than fully anonymous.
Supporting information: Study protocol, Informed consent form
Time frame: Available from December 2026 to December 2028, beginning after publication of the main results.
Access criteria: Qualified researchers may request access from the principal investigator. Access requires independent research ethics committee approval, a signed data use agreement, and compliance with consent and confidentiality requirements. No open repository deposit.
No publications or documents are linked to this record.
Ran from Jul 2025 to primary completion in Jun 2026, 10 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 23, 2026: start Sep 2025 → Jul 2025, primary completion Mar 2026 → Jun 2026 and completion Mar 2026 → Jun 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.